Piramal settles desflurane litigation with Baxter, set to begin US manufacture in 2012
This article was originally published in Scrip
Executive Summary
Piramal Critical Care, part of India's Piramal group, can manufacture desflurane, a generic version of Baxter's Suprane inhaled anaesthetic agent, in the US next year as part of a patent litigation settlement for the product.